hERG channel trafficking: novel targets in drug-induced long QT syndrome
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
The cardiac potassium channel hERG (human ether-a-go-go-related gene) encodes the α-subunit of the rapid delayed rectifier current IKr in the heart, which contributes to terminal repolarization in human cardiomyocytes. Direct block of hERG/IKr channels by a large number of therapeutic compounds produces acLQTS [acquired LQTS (long QT syndrome)] characterized by drug-induced QT prolongation and torsades de pointes arrhythmias. The cardiotoxicity associated with unintended hERG block has prompted pharmaceutical companies to screen developmental compounds for hERG blockade and made hERG a major target in drug safety programmes. More recently, a novel form of acLQTS has been discovered that may go undetected in most conventional safety assays. Several therapeutic compounds have been identified that reduce hERG/IKr currents not by direct block but by inhibition of hERG/IKr trafficking to the cell surface. Important examples are antineoplastic Hsp90 (heat-shock protein 90) inhibitors such as (i) geldanamycin, (ii) the leukaemia drug arsenic trioxide, (iii) the antiprotozoical pentamidine, (iv) probucol, a cholesterol-lowering drug, and (v) fluoxetine, a widely used antidepressant. Increased awareness of drug-induced hERG trafficking defects will help to further reduce the potentially lethal adverse cardiac events associated with acLQTS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ich function is dependent upon their appropriate location and abundance within the cells, which is regulated by a delicate equilibrium between endocytic, secretory, and degradative pathways [79,80,81].”
From Insights of Endocytosis Signaling in Health and Disease (2023) · cites this paper as [81]
Citations
Cites
Sanguinetti, M. C., Jiang, C., Curran, M. E., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90340-2 · Cited by 2,423
hERG potassium channels and cardiac arrhythmia
Sanguinetti, M. C., & Tristani-Firouzi, M. (2006) · Nature · doi:10.1038/nature04710 · Cited by 1,572
Molecular and Cellular Mechanisms of Cardiac Arrhythmias
Keating, M. T., & Sanguinetti, M. C. (2001) · Cell · doi:10.1016/s0092-8674(01)00243-4 · Cited by 1,001
Hieronymus, H., Lamb, J., Ross, K. N., Peng, X. P., Clement, C., Rodina, A., Nieto, M., Du, J., Stegmaier, K., Raj, S. M., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.09.005 · Cited by 624
Heat shock protein 90 as a molecular target for cancer therapeutics
Isaacs, J. S., Xu, W., & Neckers, L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00029-1 · Cited by 577
The impact of drug-induced QT interval prolongation on drug discovery and development
Fermini, B., & Fossa, A. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1108 · Cited by 492
Most LQT2 Mutations Reduce Kv11.1 (hERG) Current by a Class 2 (Trafficking-Deficient) Mechanism
Anderson, C. L., Delisle, B. P., Anson, B. D., Kilby, J. A., Will, M. L., Tester, D. J., Gong, Q., Zhou, Z., Ackerman, M. J., & January, C. T. (2006) · Circulation · doi:10.1161/circulationaha.105.570200 · Cited by 408
Drug‐Induced Torsades de Pointes and Implications for Drug Development
FENICHEL, R. R., MALIK, M., ANTZELEVITCH, C., SANGUINETTI, M., RODEN, D. M., PRIORI, S. G., RUSKIN, J. N., LIPICKY, R. J., CANTILENA, L. R., & Independent Academic Task Force (2004) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2004.03534.x · Cited by 346
Role of the Cytosolic Chaperones Hsp70 and Hsp90 in Maturation of the Cardiac Potassium Channel hERG
Ficker, E., Dennis, A. T., Wang, L., & Brown, A. M. (2003) · Circulation Research · doi:10.1161/01.res.0000079028.31393.15 · Cited by 323
Self-citationPredicting drug–hERG channel interactions that cause acquired long QT syndrome
Sanguinetti, M. C., & Mitcheson, J. S. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.01.003 · Cited by 300
Cited by
Items 101–145 of 145
Bialecki, R., Lainée, P., & Valentin, J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00718-1 · Cited by 3
Bialecki, R. A., Lainée, P., & Valentin, J.-P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64976-0 · Cited by 2
Kv11.1 (hERG1) Channels and Cardiac Arrhythmia
Sanguinetti, M. C. (2023) · Springer eBooks · doi:10.1007/978-3-031-33588-4_11 · Cited by 2
Meier, S., Savchenko, A. S., Volders, P. G. A., & Heijman, J. (2026) · The Journal of Physiology · doi:10.1113/jp290425 · Cited by 2
Dong, Z., Shi, Y., Feng, L., Shen, Z., Li, F., Zheng, S., Hai, X., & Li, B. (2017) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21966 · Cited by 2
Assessment of temperature‐induced hERG channel blockade variation by drugs
Kauthale, R. R., Dadarkar, S. S., Husain, R., Karande, V. V., & Gatne, M. M. (2017) · Journal of Applied Toxicology · doi:10.1002/jat.3447 · Cited by 2
AlRawashdeh, S., Mosa, F. E. S., & Barakat, K. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1341727 · Cited by 1
Metals in Environmental Cardiovascular Diseases
Barchowsky, A. (2010) · Royal Society of Chemistry eBooks · doi:10.1039/9781849732307-00272 · Cited by 1
Townsend, C. Y. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.99998-5 · Cited by 1
Computational Modeling of Cardiac K+ Channels and Channelopathies
Pérez, L. R., Noskov, S. Y., & Clancy, C. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802002-9.00012-1 · Cited by 1
Gonzalez, N. S., García‐Álvarez, A., Braña, I., Tabernero, J. M., & Oristrell, G. (2023) · Springer eBooks · doi:10.1007/978-3-030-93702-7_14-1 · Cited by 1
Bialecki, R., Gallacher, D. J., & Valentin, J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00070-x · Cited by 1
Traebert, M., & Dumotier, B. M. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511779053.005 · Cited by 1
The thorough QT study: let's be precise.
Wedam, E. F., & Haigney, M. C. (2011) · PubMed · Cited by 1
Acquired long QT syndrome and sex hormones
Odening, K. E., & Castiglione, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817728-0.00073-5 · Cited by 1
Kiviaho, A. (2014) · Tampere University Institutional Repository (Tampere University) · Cited by 1
Inhibitors of hERG Channel Trafficking
Yeung, K. S., & Meanwell, N. A. (2013) · Annual reports in medicinal chemistry · doi:10.1016/b978-0-12-417150-3.00021-1 · Cited by 1
Construction of recombinant plasmid pEGFP-C2-L539fs/47 and its expression in HEK293 cells
Lü, Y., Aifeng, Z., Han, W., Li, G., Junbo, Z., Gao, J., Junqiang, P., Zhang, Y., & Chaofeng, S. (2012) · 中国人民解放军军医大学学报:英文版 · doi:10.1016/s1000-1948(12)60014-8 · Cited by 1
Metals and Cardiovascular Disease
Barchowsky, A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00721-1
Townsend, C. Y. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00003-7
Integrated Risk Assessment of Cardiovascular Safety in Drug Discovery
Erdemli, G., & Martin, R. L. (2014) · Wiley eBooks · doi:10.1002/9781118783344.ch18
Genetic Mechanisms of Arrhythmia
Priori, S. G., Napolitano, C., & MacRae, C. A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381510-1.00042-9
ZHANG, J., Lü, Y., Zhang, A., Sun, C., Wenqi, H. A. N., Li, G., Jie, G. A. O., Huo, J., Junqiang, P., Zhou, X., et al. (2013) · 中国人民解放军军医大学学报:英文版 · doi:10.1016/s1000-1948(13)60034-9
Potassium Channels Implicated in the Short QT Syndrome
Adeniran, I. (2014) · Springer theses · doi:10.1007/978-3-319-07200-5_2
Soldovieri, M. V., & Taglialatela, M. (2010) · Wiley eBooks · doi:10.1002/9780470660379.ch3
Single Cell Imaging Cytometry‐Based High‐Throughput Analysis of Drug‐Induced Cardiotoxicity
Kim, M. J., & Song, J. M. (2013) · Wiley eBooks · doi:10.1002/9781118538203.ch21
hERG1 Channel Blockers and Cardiac Arrhythmia
Sanguinetti, M. C., & Perry, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-17575-6_34
Foo, B. (2019) · eScholarship@McGill (McGill) · doi:10.82308/5192
Metals and Cardiovascular Disease
Barchowsky, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00262-x
Data from Impact of ABCB1 Allelic Variants on QTc Interval Prolongation
Sissung, T. M., Gardner, E. R., Piekarz, R., Howden, R., Chen, X., Woo, S., Franke, R. M., Clark, J. A., Miller‐DeGraff, L., Steinberg, S. M., et al. (2023) · doi:10.1158/1078-0432.c.6518514
Protein kinase-dependent Kv1.3 biology
Estadella Pérez, I. (2023) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
de la Fuente, M. G. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Muñoz, A. B. (2014) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Dolz-Gaitón, P. (2014) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
ヒトES細胞由来心筋細胞を用いた新規医薬品心毒性予測システムの開発と検証
Asahi, Y. (2020) · Institutional Repositories DataBase (IRDB) · doi:10.15083/0002006099
Defining New Mechanistic Roles for αII Spectrin in Cardiac Function and Excitability
Lubbers, E. R. (2019) · OhioLink ETD Center (Ohio Library and Information Network)
Inhibitory Effect of Nicardipine on hERG Channel
Chung, E., Cho, H., Cha, J.-H., Kwon, K.-J., Jeon, S.-H., Jo, S., Kim, E.-J., Kim, H.-S., & Chung, H.-J. (2010) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2010.18.4.448
Jin, X., Sun, A., Wang, K., Zou, Y., & Ge, J. (2008) · Bioscience hypotheses · doi:10.1016/j.bihy.2008.08.003
Mokhtar, N. F., & Hussin, M. F. (2017) · Cardiology and Cardiovascular Medicine · doi:10.26502/fccm.92920028
LncRNA MALAT1/calpain-1 axis in ATO/hypoxia induced hERG channel deficiencyPreprint
Li, B., Yan, C., Li, Y., Li, Y., Zhang, Y., Guo, J., Yu, W., Ren, J., Zhang, Y., & Zhao, X. Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1837090/v1
Kinetics and state-dependence of drug-binding to Kv11.1
Perrin, M. J. (2009) · UNSWorks (University of New South Wales, Sydney, Australia) · doi:10.26190/unsworks/23153
Advancing arrhythmia diagnostics in cardiology and cardio-oncology - from bench to bedside
Phan, J. A.-K. (2026) · UNSWorks (UNSW Sydney) · doi:10.26190/unsworks/32692
Ma, Y., Yang, J., Zheng, X., Chen, H., Liu, J., & Liu, H. (2026) · Cardiovascular Toxicology · doi:10.1007/s12012-026-10225-5
Metadata
- Authors
- Dennis, A., Wang, L., Wan, X., & Ficker, E.
- Affiliations
- MetroHealth (US)
- Venue
- Biochemical Society Transactions
- Publisher
- Portland Press Ltd.
- Published
- 2007-10-25
- Volume
- 35
- Issue
- 5
- Pages
- 1060-1063
- ISSN
- 0300-5127 (ISSN-L)
- 1470-8752
- OpenAlex
- W2063315937
- Cited by
- 134
- References
- 28
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 7 · 2022: 2 · 2021: 4 · 2020: 5 · 2019: 4 · 2018: 5 · 2017: 8 · 2016: 7 · 2015: 4 · 2014: 14 · 2013: 14 · 2012: 8
- FWCI
- 7.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemical Society Transactions (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
- Keywords
- hERG, drug-induced long QT syndrome, acquired long QT syndrome, channel trafficking, cardiac potassium channels, IKr current, torsades de pointes, drug-induced cardiotoxicity, Hsp90 inhibitors, geldanamycin, arsenic trioxide, pentamidine, probucol, fluoxetine, drug safety testing
- MeSH terms
- ERG1 Potassium Channel, Humans, Long QT Syndrome, HSP90 Heat-Shock Proteins, Protein Transport, Ether-A-Go-Go Potassium Channels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.